Edition:
United States

Regulus Therapeutics Inc (RGLS.OQ)

RGLS.OQ on NASDAQ Stock Exchange Capital Market

1.11USD
18 Jan 2019
Change (% chg)

$0.03 (+2.78%)
Prev Close
$1.08
Open
$1.10
Day's High
$1.12
Day's Low
$1.03
Volume
52,701
Avg. Vol
70,659
52-wk High
$17.22
52-wk Low
$0.80

Latest Key Developments (Source: Significant Developments)

Regulus Therapeutics Files For Common Stock Offering Of Up To $20 Mln
Wednesday, 12 Dec 2018 05:08pm EST 

Dec 12 (Reuters) - Regulus Therapeutics Inc ::REGULUS THERAPEUTICS INC FILES FOR COMMON STOCK OFFERING OF UP TO $20.0 MILLION - SEC FILING.  Full Article

Regulus Therapeutics - On Nov 13, Nasdaq Notified Co
Friday, 16 Nov 2018 04:25pm EST 

Nov 16 (Reuters) - Regulus Therapeutics Inc ::REGULUS THERAPEUTICS - ON NOV 13, NASDAQ NOTIFIED CO'S STOCKHOLDERS' EQUITY DOES NOT SATISFY NASDAQ GLOBAL MARKET CONTINUED LISTING REQUIREMENT.  Full Article

Regulus Therapeutics Says To Incur Charges Of About $1.5 Mln For Employee Severance & Other Termination Benefits
Friday, 6 Jul 2018 05:25pm EDT 

July 6 (Reuters) - Regulus Therapeutics Inc ::REGULUS THERAPEUTICS - TO INCUR CHARGES OF ABOUT $1.5 MILLION FOR EMPLOYEE SEVERANCE & OTHER TERMINATION BENEFITS REGARDING 60 PERCENT WORKFORCE REDUCTION.REGULUS THERAPEUTICS SAYS SEVERANCE PAYMENTS ARE EXPECTED TO BE PAID IN FULL BY THE END OF Q3 2018 - SEC FILING.  Full Article

Regulus Therapeutics Q3 loss per share $0.18
Tuesday, 7 Nov 2017 07:16pm EST 

Nov 7 (Reuters) - Regulus Therapeutics Inc ::Regulus reports third quarter 2017 financial results and recent events.Q3 revenue was less than $100,000.Q3 loss per share $0.18.Q3 revenue view $864,000 -- Thomson Reuters I/B/E/S.Q3 earnings per share view $-0.16 -- Thomson Reuters I/B/E/S.  Full Article

Regulus Q3 loss per share $0.18
Tuesday, 7 Nov 2017 04:10pm EST 

Nov 7 (Reuters) - Regulus Therapeutics Inc ::Regulus reports third quarter 2017 financial results and recent events.Q3 revenue $100,000.Q3 loss per share $0.18.Q3 revenue view $864,000 -- Thomson Reuters I/B/E/S.Q3 earnings per share view $-0.16 -- Thomson Reuters I/B/E/S.  Full Article